U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07404735) titled 'A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846' on Jan. 29.

Brief Summary: A Clinical trial to compare and evaluate evaluate the pharmacokinetics and safety of CKD-846

Study Start Date: Feb. 23

Study Type: INTERVENTIONAL

Condition: Benign Prostate Hypertrophy(BPH)

Intervention: DRUG: CKD-846

once administration of Investigational Product

DRUG: D091

once administration of Investigational Product

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chong Kun Dang Pharmaceutical

Disclaimer: Curated by HT Syndication....